Načítá se...
Vaccines, adjuvants and dendritic cell activators – Current Status and Future Challenges
Cancer vaccines offer a low-toxicity approach to induce anticancer immune responses. They have shown promise for clinical benefit with one cancer vaccine approved in the U.S. for advanced prostate cancer. As other immune therapies are now clearly effective for treatment of advanced cancers of many h...
Uloženo v:
| Vydáno v: | Semin Oncol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4621212/ https://ncbi.nlm.nih.gov/pubmed/26320060 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminoncol.2015.05.006 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|